Multicenter-based cross-sectional and longitudinal study in China (IMAGE)
Caption
A total of 817 participants were recruited to evaluate potential alterations in blood-based biomarkers for AD among different clinical groups, including AD dementia, non-AD dementia, and vascular diseases such as cerebral amyloid angiopathy (CAA) and cerebral small vessel disease (CSVD), within a Chinese multicenter cohort.
Credit
©Science China Press
Usage Restrictions
Use with credit.
License
Original content